Cargando…

MELK promotes Endometrial carcinoma progression via activating mTOR signaling pathway

BACKGROUND: Endometrial carcinoma (EC) is one of the most common gynecological malignancies among women. Maternal embryonic leucine Zipper Kinase (MELK) is upregulated in a variety of human tumors, where it contributes to malignant phenotype and correlates with a poor prognosis. However, the biologi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Qinyang, Ge, Qiulin, Zhou, Yang, Yang, Bikang, Yang, Qin, Jiang, Shuheng, Jiang, Rongzhen, Ai, Zhihong, Zhang, Zhigang, Teng, Yincheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Research paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7000338/ https://www.ncbi.nlm.nih.gov/pubmed/31915116 http://dx.doi.org/10.1016/j.ebiom.2019.102609

Ejemplares similares

A study on the timing of uterine artery embolization followed by pregnancy excision for cesarean scar pregnancy: a prospective study in China
por: Yu, Liping, et al.
Publicado: (2021)

CDK12 Promotes Cervical Cancer Progression through Enhancing Macrophage Infiltration
por: Yang, Bikang, et al.
Publicado: (2021)

xCT contributes to colorectal cancer tumorigenesis through upregulation of the MELK oncogene and activation of the AKT/mTOR cascade
por: Tang, Bufu, et al.
Publicado: (2022)

SRSF10-mediated IL1RAP alternative splicing regulates cervical cancer oncogenesis via mIL1RAP-NF-κB-CD47 axis
por: Liu, Fei, et al.
Publicado: (2018)

Inhibiting Importin 4-mediated nuclear import of CEBPD enhances chemosensitivity by repression of PRKDC-driven DNA damage repair in cervical cancer
por: Zhou, Yang, et al.
Publicado: (2020)

TNPO1-Mediated Nuclear Import of FUBP1 Contributes to Tumor Immune Evasion by Increasing NRP1 Expression in Cervical Cancer
por: Yang, BiKang, et al.
Publicado: (2021)

Increased Nuclear Transporter Importin 7 Contributes to the Tumor Growth and Correlates With CD8 T Cell Infiltration in Cervical Cancer
por: Chen, Jing, et al.
Publicado: (2021)

miR-21-5p Inhibits Ferroptosis in Hepatocellular Carcinoma Cells by Regulating the AKT/mTOR Signaling Pathway through MELK
por: Hu, Zongqiang, et al.
Publicado: (2023)

mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
por: Zou, Zhilin, et al.
Publicado: (2020)

UPF1 impacts on mTOR signaling pathway and autophagy in endometrioid endometrial carcinoma
por: Zhang, Minfen, et al.
Publicado: (2021)

VEGF-mTOR signaling links obesity and endometrial cancer
por: Sahoo, Subhransu S., et al.
Publicado: (2018)

The Role of mTOR and eIF Signaling in Benign Endometrial Diseases
por: Driva, Tatiana S., et al.
Publicado: (2022)

mTOR-Dependent Role of Sestrin2 in Regulating Tumor Progression of Human Endometrial Cancer
por: Shin, Jiha, et al.
Publicado: (2020)

mTOR: An attractive therapeutic target for osteosarcoma?
por: Ding, Liu, et al.
Publicado: (2016)

HDAC6, modulated by miR-206, promotes endometrial cancer progression through the PTEN/AKT/mTOR pathway
por: Zheng, Yawen, et al.
Publicado: (2020)

Overexpression of ARHGAP30 suppresses growth of cervical cancer cells by downregulating ribosome biogenesis
por: Wu, Aijia, et al.
Publicado: (2021)

Aurora-A Induces Chemoresistance Through Activation of the AKT/mTOR Pathway in Endometrial Cancer
por: Wu, Jun, et al.
Publicado: (2019)

Overactive mTOR signaling leads to endometrial hyperplasia in aged women and mice
por: Bajwa, Preety, et al.
Publicado: (2016)

Association of Membranous WNT-1 and Nuclear mTOR with Endometrial Cancer Grade
por: Pietrus, Milosz, et al.
Publicado: (2023)

miR-205 inhibits cell growth by targeting AKT-mTOR signaling in progesterone-resistant endometrial cancer Ishikawa cells
por: Zhuo, Zhihong, et al.
Publicado: (2017)

Chrysin induces autophagy through the inactivation of the ROS-mediated Akt/mTOR signaling pathway in endometrial cancer
por: He, Yu, et al.
Publicado: (2021)

Control of mTOR Signaling by Ubiquitin
por: Jiang, Yao, et al.
Publicado: (2019)

The Translational Regulation in mTOR Pathway
por: Yang, Miaomiao, et al.
Publicado: (2022)

Targeting mTOR for cancer therapy
por: Hua, Hui, et al.
Publicado: (2019)

mTOR Pathway and mTOR Inhibitors in Head and Neck Cancer
por: Gao, Wei, et al.
Publicado: (2012)

CMTM6 knockdown prevents glioma progression by inactivating the mTOR pathway
por: Wei, Li, et al.
Publicado: (2022)

Role of mTOR inhibitor in cholangiocarcinoma cell progression
por: MOOLTHIYA, PENPAK, et al.
Publicado: (2014)

MELK is Upregulated in Advanced Clear Cell Renal Cell Carcinoma and Promotes Disease Progression by Phosphorylating PRAS40
por: Zhang, Han, et al.
Publicado: (2019)

Reversion of Hormone Treatment Resistance with the Addition of an mTOR Inhibitor in Endometrial Stromal Sarcoma
por: Martin-Liberal, J., et al.
Publicado: (2014)

Myelination and mTOR
por: Figlia, Gianluca, et al.
Publicado: (2017)

MELK is an oncogenic kinase essential for metastasis, mitotic progression, and programmed death in lung carcinoma
por: Tang, Qin, et al.
Publicado: (2020)

Duck Tembusu virus induces incomplete autophagy via the ERK/mTOR and AMPK/mTOR signalling pathways to promote viral replication in neuronal cells
por: Wang, Qing, et al.
Publicado: (2023)

STYX/FBXW7 axis participates in the development of endometrial cancer cell via Notch–mTOR signaling pathway
por: Liu, Liheng, et al.
Publicado: (2020)

Genotype-Dependent Efficacy of a Dual PI3K/mTOR Inhibitor, NVP-BEZ235, and an mTOR Inhibitor, RAD001, in Endometrial Carcinomas
por: Shoji, Keiko, et al.
Publicado: (2012)

ESM1 promotes angiogenesis in colorectal cancer by activating PI3K/Akt/mTOR pathway, thus accelerating tumor progression
por: Yang, Liqun, et al.
Publicado: (2023)

PSMC2 promotes the progression of gastric cancer via induction of RPS15A/mTOR pathway
por: Liu, Tao, et al.
Publicado: (2022)

Pml represses tumour progression through inhibition of mTOR
por: Bernardi, Rosa, et al.
Publicado: (2011)

Elevated kindlin-2 promotes tumour progression and angiogenesis through the mTOR/VEGFA pathway in melanoma
por: Wei, Chuan-Yuan, et al.
Publicado: (2019)

mTOR Signaling in Cancer and mTOR Inhibitors in Solid Tumor Targeting Therapy
por: Tian, Tian, et al.
Publicado: (2019)

Regulation of Osteoclast Growth and Fusion by mTOR/raptor and mTOR/rictor/Akt
por: Tiedemann, Kerstin, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_nkditi52bphd3kj67e65074dqb